Objectives: To evaluate the effectiveness of the proximal optimization technique (POT) to prevent longitudinal stent elongation.
| INTRODUCTION
Longitudinal stent deformation, which is defined as the distortion of a stent in the longitudinal axis, [1] [2] [3] is a relatively common stent complication during percutaneous coronary intervention (PCI) procedures. 3, 4 Longitudinal stent deformation has been reported to cause major complications including stent thrombosis, emergency coronary artery bypass graft, and death, which accounts for 7% and 14% of cases in two reports from the MAUDAE complication database. [1] [2] [3] [5] [6] [7] [8] Although longitudinal stent deformation is mainly described as focal or overall longitudinal stent shortening, some recent case reports have also described the occurrence of longitudinal stent elongation as a type of longitudinal stent deformation. [9] [10] [11] Previous reports have identified predictors of longitudinal stent deformation including stent design, post-balloon dilatation, complex lesions, guide extension catheter devices, and low stent inflation pressure. [9] [10] [11] A study using intravascular ultrasound (IVUS) reported that post-balloon dilatation after stent deployment often leads to longitudinal stent deformation as a mechanical complication. 12 However, the mechanism underlying this relationship is still unclear. The purpose of this study was to evaluate the relation between the range of stent malapposition and occurrence of longitudinal stent elongation using optical coherence tomography (OCT). In addition, we examined the validity of the proximal optimization technique (POT) to prevent longitudinal stent elongation.
| METHODS
We retrospectively analyzed 578 consecutive lesions in 442 patients who underwent OCT during a PCI procedure at Tokyo Medical and Dental University Hospital between May 2013 and November 2017 based on electronic medical charts. We selected the lesions in which OCT was performed just after stent deployment and after post-balloon dilatation. The post-balloon dilatation procedure consisted of conventional distal-to-proximal balloon dilatation until September 2016, and subsequently, the POT was used. We refer to the former cases as the non-POT cohort, and the latter as the POT cohort. In the non-POT cohort, post-dilatation was performed from the distal part with insufficient stent expansion or stent malapposition to the proximal stent edge. The point where the post-dilatation was started was determined by each operator from angiographical findings or OCT findings. On the other hand, in the POT cohort, post-dilatation was performed from the proximal stent edge to distal portion of stent where post-dilatation was needed. As in the non-POT cohort, the range of post-dilatation was determined by the operator form angiographic and OCT findings.
We excluded lesions with stent lengths less than 30 mm, those where OCT devices were not delivered to target lesion, those where post-balloon dilatation was not warranted, and those where stent deformations were caused by a guide extension catheter. The lesions were divided into two groups according to the range of malapposition at the stent edge as evaluated by OCT just after stent deployment.
In the non-POT cohort, the malapposition angle at the proximal 
| STATISTICAL ANALYSIS
Continuous variables were expressed as mean ± standard deviation or median with inter-quartile range, and categorical variables were described using frequencies and percentages. A P-value <0.05 was considered statistically significant. The independent-samples t-test or Wilcoxon-Mann-Whitney test was used to compare continuous variables. Categorical variables were compared using the chi square
. Among the stents with stents showing malapposition after deployment, which refers to the malapposition group groups in both non-POT and POT cohorts, univariate logistic regression analyses were performed to examine the predictors of longitudinal stent elongation. Multivariable analysis was avoided due to the limited sample size. Statistical analyses were performed using JMP® 12 (SAS Institute Inc., Cary, NC).
| RESULTS
Between May 2013 and August 2016, we identified 72 stent-treated lesions in 67 patients that underwent OCT both just after stent deployment and post-balloon dilatation, which comprised the non-POT cohort (Figure 1 ). In this cohort, 54 lesions were included in wellapposed strut group and 18 lesions were in malapposition group.
Patient characteristics and lesion characteristics were almost similar between the two groups except that malapposition group had significantly higher rates of dyslipidemia and significantly lower rates of tortuosity than well-apposed strut group (Table 1) . Stent diameter and length were similar between the two groups. Stent elongation length was significantly longer in the malapposition group than in the well-apposed strut group (1.51 ± 1.34 mm vs 0.13 ± 0.84 mm, P < 0.01) (Figures 2 and 3 ). Table S1 ). When we compared the prevalence of stent types between the stent with longitudinal stent elongation and those without, no significant differences were observed (supplemental Tables S2 and S3 ).
Univariate logistic regression analyses revealed that POT and maximum inflation pressure for post-balloon dilatation were significantly associated with longitudinal stent elongation (OR 0.03 [95%CI 0.00-0.24], P < 0.01 and OR 1.46 [95%CI 1.14-2.16], P = 0.01, respectively) (Supplemental Table S4 ).
| DISCUSSION
According to the results of the non-POT cohort, the occurrence of longitudinal stent elongation after post-balloon dilatation was significantly greater when the angle of malapposition at the stent edge exceeded 180°, compared to angles less than 180°. A previous IVUS study found that the incidence of malapposition after DES deployment was 7.2% overall, and 34.3% in patients with acute myocardial infarction. 13 Post-balloon dilatation to resolve stent malapposition might cause longitudinal stent elongation, a type of longitudinal stent deformation, which could cause major complications. [1] [2] [3] [5] [6] [7] [8] Although the clinical implications of stent malapposition are controversial, some lesion characteristics, such as calcification and severe diameter stenosis, have been reported to be predictive of acute stent malapposition that occurs during a PCI procedure. 14 We hypothesized that, as the mechanism of this longitudinal stent elongation after post-balloon dilatation, although the force of postballoon dilatation typically exerted toward the radial axis of the for complete circular correction of expected proximal strut malapposition. 16, 17 In an ex-vivo study, Sumi et al 18 found the distal-toproximal post-balloon dilatation showed linear elongation during each step of post-balloon dilatation. In contrast, during the proximal-todistal post-balloon dilatation, the most significant change was observed in the first step of post-dilatation and only slight changes were observed thereafter. They also detected OFDI analysis indicated that the frequency of stent strut malapposition was positively correlated with the percentage change in stent length (r = 0.74, P < 0.0001). In the POT cohort of the present study, the extent of longitudinal stent elongation was not different between well-apposed group and malapposed group, which were close to zero in the mean value, which corroborates the previous study.
Recent reports have identified risk factors for stent deformation, which included stent design; post-balloon dilatation; complex lesions; ostial, bifurcation, and left main trunk lesions; extra support devices; guiding catheter; guidewires; and low stent inflation pressure. [9] [10] [11] In addition to the procedural and morphological characteristics, stent types have been reported to be associated with stent deformation. A previous OCT study reported that, compared to cobalt-chromium everolimus-eluting stents, platinum-chromium everolimus-eluting stents showed a lower tendency for malapposed struts, 19 but in contrast, recent studies reported that the Promus Element® stent (platinum-chromium stent) often demonstrated deformation 8, 9, 20 The vast majority of stent design included in this study was second-and third-generation drug eluting stents (Supplemental Table S1 ). In this study, Promus Element® stents were used in seven lesions and the mean stent elongation length of these lesions was −0.12 ± 0.62 mm, which was close to zero. Besides Promus Element stents, stent designs showed no significant association with longitudinal stent elongation in both cohorts (supplemental Tables S2 and S3 ), which highlighted the importance of technical issue rather than stent designs.
A representative case of longitudinal stent elongation in the non-POT cohort is shown in Figure 7 .
| LIMITATIONS
First, given a limited study population performed in a single center with a retrospective study design, selection bias, and recall bias can not be canceled. Second, not all lesions were observed by OCT imaging devices because of difficulty in passing the devices or insufficient removal of blood cells. Third, the impact of patient and lesion characteristics such as dyslipidemia, tortuosity, calcification, bifurcation, and stent diameter, which showed significant or non-significant differences between well-apposed and malapposed groups, could not be determined multivariate analysis due to the limited sample size, which may have represented a selection bias. Forth, because this study is small sample size and retrospective study, there were some difficulties in usage of the same stent designs both in the non-POT cohort and the POT cohort. Lastly, stent length was measured on the longitudinal reconstruction image of OCT, and OCT catheter did not necessarily exist on the center line of the stent. Therefore, accordion effect in the tortuous vessel may have affected the measurements.
| CONCLUSIONS
Malapposition at the stent edge was associated with longitudinal stent elongation caused by post-balloon dilatation. In the lesions treated with POT, longitudinal stent elongation rarely occurred unlike the lesions treated with conventional post-dilatation from distal to proximal portion. POT may be potentially effective to minimize the longitudinal stent elongation by post-balloon dilatation in lesions with malapposition, which warrants further investigation in a prospective study design.
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